Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Anthony Butler is an analyst at EF Hutton. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/27/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/09/2023 | ATRA | Buy Now | Atara Biotherapeutics | $6.88 | 263.37% | Anthony Butler19% | $625 → $625 | Reiterates | Buy → Buy | Get Alert |
| 02/09/2023 | ATRA | Buy Now | Atara Biotherapeutics | $6.88 | 263.37% | Anthony Butler19% | $625 → $625 | Reiterates | → Buy | Get Alert |
| 02/09/2023 | RAIN | Buy Now | Rain Oncology | $1.95 | 720.51% | Anthony Butler19% | → $16 | Reiterates | → Buy | Get Alert |
| 01/05/2023 | ARAV | Buy Now | Aravive | — | — | Anthony Butler19% | → $10 | Initiates | → Buy | Get Alert |
| 06/03/2022 | ARAV | Buy Now | Aravive | — | — | Anthony Butler19% | → $15 | Initiates | → Buy | Get Alert |
| 01/03/2019 | INCY | Buy Now | Incyte | $60.68 | — | Anthony Butler19% | — | Upgrade | Neutral → Buy | Get Alert |
| 04/06/2018 | INCY | Buy Now | Incyte | $60.68 | — | Anthony Butler19% | — | Downgrade | Buy → Neutral | Get Alert |
